Perspectives from man's best friend: National academy of medicine's workshop on comparative oncology

Science Translational Medicine

Volumn 8, Issue 324, 2016, Pages

  Leblanc, Amy K ^a   Breen, Matthew ^b   Choyke, Peter ^a   Dewhirst, Mark ^c   Fan, Timothy M ^d   Gustafson, Daniel L ^e   Helman, Lee J ^a   Kastan, Michael B ^f   Knapp, Deborah W ^g   Levin, Wendy J ^h   London, Cheryl ⁱ   Mason, Nicola ⁱ   Mazcko, Christina ^a   Olson, Patricia N ^j   Page, Rodney ^e   Teicher, Beverly A ^a   Thamm, Douglas H ^e   Trent, Jeffrey M ^k   Vail, David M ^l   Khanna, Chand ^m,n  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e Veterinary Dentistry and Oral Surgery   (United States)

^f DUKE CANCER INSTITUTE   (United States)

^g PURDUE UNIVERSITY   (United States)

^h Fate Therapeutics Inc   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j Animal Health and Welfare   (United States)

^k TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF WISCONSIN MADISON   (United States)

^m Ethos Discovery   (United States)

ⁿ ETHOS VETERINARY HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; COMPARATIVE ONCOLOGY; COMPARATIVE STUDY; DOG; DRUG DEVELOPMENT; DRUG RESEARCH; GENE SEQUENCE; HUMAN; MEDICAL PRACTICE; NONHUMAN; ONCOLOGY; PET ANIMAL; PRIORITY JOURNAL; REVIEW; SPECIES COMPARISON; STUDY DESIGN; TRANSLATIONAL RESEARCH; ANIMAL; CLINICAL TRIAL (TOPIC); EDUCATION; HEALTH CARE ORGANIZATION; NEOPLASMS; ORGANIZATION;

ACADEMIES AND INSTITUTES; ANIMALS; CLINICAL TRIALS AS TOPIC; DOGS; DRUG DISCOVERY; EDUCATION; HUMANS; NEOPLASMS; SOCIETIES, SCIENTIFIC;

EID: 84958087523     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf0746     Document Type: Review

References (10)

1. D. M. Vail, E. G. MacEwen, Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 18, 781-792 (2000).
2. I. Gordon, M. Paoloni, C. Mazcko, C. Khanna, The Comparative Oncology Trials Consortium: Using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLOS Med. 6, e1000161 (2009).
3. C. Khanna, C. London, D. Vail, C. Mazcko, S. Hirschfeld, Guiding the optimal translation of new cancer treatments from canine to human cancer patients. Clin. Cancer Res. 15, 5671-5677 (2009).
4. J. D. Schiffman, M. Breen, Comparative oncology: What dogs and other species can teach us about humans with cancer. Philos. Trans. R. Soc. London B Biol. Sci. 370, 20140231 (2015).
5. M. Breen, J. F. Modiano, Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans-Man and his best friend share more than companionship. Chromosome Res. 16, 145-154 (2008).
6. B. Decker, H. G. Parker, D. Dhawan, E. M. Kwon, E. Karlins, B. W. Davis, J. A. Ramos-Vara, P. L. Bonney, E. A. McNiel, D. W. Knapp, E. A. Ostrander, Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer-Evidence for a relevant model system and urine-based diagnostic test. Mol. Cancer Res. 13, 993-1002 (2015).
7. M. Paoloni, S. Davis, S. Lana, S. Withrow, L. Sangiorgi, P. Picci, S. Hewitt, T. Triche, P. Meltzer, C. Khanna, Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. BMC Genomics 10, 625 (2009).
8. C. Mazcko, R. Thomas, The establishment of the Pfizercanine comparative oncology and genomics consortium biospecimen repository. Vet. Sci. 22, 127-130 (2015).
9. A. K. LeBlanc, Cancer and comparative imaging. ILAR J. 55, 164-168 (2014).
10. A. K. LeBlanc, C. N. Mazcko, C. Khanna, Defining the value of a comparative approach to cancer drug development. Clin. Cancer Res. 28 December 2015 (clincanres.2337.2015) [epub ahead of print].